An overview on the impact of viral pathogens on Alzheimer's disease

被引:0
|
作者
Amelimojarad, Melika [1 ]
Amelimojarad, Mandana [1 ]
Cui, Xiaonan [1 ]
机构
[1] Dalian Med Univ, Affiliate Hosp 1, Dept Oncol, Zhongshan Rd, Dalian 116011, Liaoning, Peoples R China
关键词
Alzheimer's disease; BBB; SARS-CoV-2; HSV; Viral pathogens; BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; MOUSE MODEL; IN-VITRO; MECHANISM; PROTEIN; NEUROINFLAMMATION; EXPRESSION; INFECTION; MICROGLIA;
D O I
10.1016/j.arr.2024.102615
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is the most common type of dementia which affects over than 60 million cases worldwide with higher incidence in low and middle-income countries by 2030. Based on the multifactorial nature of AD different risk factors are linked to the condition considering the brain's beta-amyloid plaques (A beta) and neurofibrillary tangles (NFTs) as its primary hallmarks. Lately, viral photogenes specially after recent SARS-CoV2 pandemic has gained a lot of attention in promoting the neurodegenerative disorder such as AD based on their capacity to increase the permeability of the blood-brain barrier, dysregulation of immune responses, and the impact on A beta processing and phosphorylation of tau proteins. Therefore, in this review, we summarized the important association of viral pathogens and their mechanism by which they contribute with AD formation and development. An overview of the roles of viral pathogens in AD: According to this figure, viruses can infect neurons directly by modulating the BBB, transferring from endothelial cells to glial cells and then to neurons, increasing the A beta deposition, and affecting the tau protein phosphorylation or indirectly through the virus's entrance and pathogenicity that can be accelerated by genetic and epigenetic factors, as well as chronic neuroinflammation caused by activated microglia and astrocytes.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] An overview of Alzheimer's disease
    Wang, SSS
    Good, TA
    JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS, 2005, 36 (06): : 533 - 559
  • [2] Overview of Alzheimer's disease
    Souder, E
    Beck, C
    NURSING CLINICS OF NORTH AMERICA, 2004, 39 (03) : 545 - +
  • [3] Alzheimer's disease: An overview
    Hamdy, RC
    SOUTHERN MEDICAL JOURNAL, 2001, 94 (07) : 661 - 662
  • [4] Pathogens as a cause of Alzheimer's disease
    Kinoshita, J
    NEUROBIOLOGY OF AGING, 2004, 25 (05) : 639 - 640
  • [5] Viral Involvement in Alzheimer's Disease
    Sait, Ahmad
    Angeli, Cristian
    Doig, Andrew J.
    Day, Philip J. R.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (07): : 1049 - 1060
  • [6] Neuroimaging in Alzheimer's disease: An overview
    Masdeu, J
    REVISTA DE NEUROLOGIA, 2004, 38 (12) : 1156 - 1165
  • [7] A review of the roles of pathogens in Alzheimer's disease
    Zhao, Meng
    Wang, Yongchun
    Shen, Yanxin
    Wei, Chunxiao
    Zhang, Guimei
    Sun, Li
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [8] Biomarkers for Alzheimer's Disease – An Overview
    Tyagi U.
    Tripathy D.B.
    Gupta A.
    Bisht K.
    Nain A.
    Macromolecular Symposia, 413 (01):
  • [9] An Association of Pathogens and Biofilms with Alzheimer's Disease
    Chakravarthi, Sandhya T.
    Joshi, Suresh G.
    MICROORGANISMS, 2022, 10 (01)
  • [10] Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview
    Catumbela, Celso S. G.
    Giridharan, Vijayasree V.
    Barichello, Tatiana
    Morales, Rodrigo
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)